SAN FRANCISCO - Marylandian -- QView Medical, the only company with FDA-approved artificial intelligence for breast ultrasound cancer detection, today announced a strategic partnership with Eve Wellness, the first company to offer direct-to-consumer breast cancer screening.

"We see Eve Wellness as the next frontier in early detection, where AI, ultrasound, and accessibility meet to give women with dense breast tissue confidence and clarity that mammography alone can't provide," said Bob Wang, CEO and founder of QView Medical.

QView's AI platform integrates with GE's Automated Breast Ultrasound (ABUS) system and is deployed in over 100 locations nationwide, including hospitals in Chicago, Atlanta, Salt Lake City, and Los Angeles. Clinical studies show the technology improves cancer detection, particularly in women with dense breast tissue, which can hide tumors in mammography.

"The important part of screening at Eve Wellness is the AI software that comes with it. The AI technology has gotten progressively better and better. It's been about three years since I have found a breast cancer that it wasn't able to pick up," said Dr. Ian Grady, Medical Director at Eve Wellness, on KRON4 TV

More on Marylandian

• New Season of MPT's Maryland Farm & Harvest Debuts November 11
• Dr. Jay A. Johannigman Delivers Lecture at the John R. Border Memorial Lectureship in Buffalo
• Powering the Next Frontier of the $1 Trillion Space Economy: Ascent Solar Technologies (N A S D A Q: ASTI)
• Taikan's T-V856S VMC Earns Prestigious 2025 Vogel Global Pioneer Award
• Maryland Permanently Preserves 14 Additional Working Farms

Eve Wellness has spent more than three years pioneering a patient-centric model that brings advanced breast cancer screening directly to women. By combining QView's FDA-approved AI with GE's 3D whole-breast ultrasound, Eve captures the entire breast, reducing the risk of missed cancers. This approach, which is then analyzed by one of the region's leading Breast Cancer physicians, offers highly effective detection in a more comfortable and convenient environment.

This model is particularly impactful for:

• Younger women under 40 who may not qualify for traditional mammography.
  
  
• Women with dense breast tissue, where mammography is known to be limited.
  
  
• Women seeking a non-invasive, more comfortable screening experience without hospital visits or physician referrals.

"Early detection saves lives, but we know mammography alone isn't enough, especially for younger women and those with dense breast tissue," said Brendan Foley, co-founder of Eve Wellness. "By combining FDA-cleared AI with 3D whole-breast ultrasound, we provide a more complete and highly effective screening experience that gives women confidence and control over their breast health."

More on Marylandian

• Flick Truck Accident Law Joins the Commercial Vehicle Safety Alliance to Strengthen Truck Safety Advocacy
• PebblePad Announces Global Partnership with Inside Higher Ed and Times Higher Education
• Passion Struck Network Debuts: A Creator-First Platform for Purpose-Driven Podcasting and Human Impact
• The Outer Rim Sci Fi Film Festival Announces Season 2 Award Winners
• The Aligned Woman Is It Well With Your Soul

QView Medical and Eve Wellness are delivering a new standard in breast screening, one that is highly effective, accessible, and centered on women's needs.

About QView Medical, Inc.
QView Medical is a Silicon Valley, venture-backed AI company that has developed FDA-approved cancer detection AI algorithms, improving early detection and diagnostic accuracy. More information: www.qviewmedical.com

About Eve Wellness
Founded in San Francisco in 2022, Eve Wellness is the first direct-to-consumer breast screening service. Using advanced 3D ultrasound and AI technology, Eve provides women a fast, comfortable, and affordable way to screen. www.myevewellness.com